Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)

Basit Öğe Kaydı
dc.contributor.authorTasci, Elif Senocak
dc.contributor.authorOyan, Basak
dc.contributor.authorSonmez, Ozlem
dc.contributor.authorMutlu, Arda Ulas
dc.contributor.authorAtci, Muhammed Mustafa
dc.contributor.authorSakin, Abdullah
dc.contributor.authorOner, Irem
dc.date.accessioned2024-10-29T17:58:50Z
dc.date.available2024-10-29T17:58:50Z
dc.date.issued2024
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1186/s12885-024-11863-0
dc.identifier.issn1471-2407
dc.identifier.issue1en_US
dc.identifier.pmid38262962
dc.identifier.scopus2-s2.0-85182828807
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1186/s12885-024-11863-0
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14518
dc.identifier.volume24
dc.identifier.wosWOS:001148300200002
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmc
dc.relation.ispartofBmc Cancer
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleComparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
dc.typeCorrection

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu